Icon

KARBINAL ER (nda022556)- (4MG/5ML)

CARBINOXAMINE MALEATE AYTU
4MG/5ML
No Yes
2029-Mar-29 Expired
None None
None No
Karbinal ER (carbinoxamine maleate) extended-release oral suspension is an H1 receptor antagonist indicated for adults and pediatric patients 2 years of age and older for the symptomatic treatment of: • Seasonal and perennial allergic rhinitis • Vasomotor rhinitis • Allergic conjunctivitis due to inhalant allergens and foods • Mild, uncomplicated allergic skin manifestations of urticaria and angioedema • Dermatographism • As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled • Amelioration of the severity of allergic reactions to blood or plasma.
0 0 0
Total Other Developers 1
Drugs with Suitability No
4MG/5ML ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.